Objective: The aim of the study was to evaluate maternal and foetal outcome after fetoreduction in higher order multiple pregnancy. 
Introduction
Recent advances in medical technology have succeeded in enabling couples who were previously considered infertile to conceive and to bear children. Through fertility drug treatment the risk of multifoetal pregnancy increases as a result of ovarian stimulation causing an increased production of ova. The procedure of in vitro fertilization often results in multifoetal pregnancy due to multiple implantations in an effort to increase the chance of successful outcome. Prior to the popularization of fertility treatments, the frequency of twin births was one in every ninety births in USA. By 1997, the frequency increased to one in 37 births. 1 While the advances in assisted reproductive technologies are benefiting many couples who would otherwise be unable to bear children, the outcomes of fertility treatments may pose maternal and fetal risks. With the increasing number of fetuses, there is an increase in the risks of fetal anomalies, premature delivery, and spontaneous abortion.
In vitro fertilization is associated with multiple pregnancy because of the insertion of multiple fertilized eggs to increase the chance of successful implantation. Premature delivery is a risk associated with multiple pregnancy that increases the risk of infant morbidity and mortality. 2 Potential maternal complications associated with multiple pregnancy are increased risk of pregnancy-induced hypertension, preeclampsia, polyhydramnios and severe anemia, as well as those general risks associated with long hospitalizations. 3 Psychosocial disturbances to the mother are associated with the above mentioned risk factors that increases with multiple pregnancy, especially in light of the fact that many of the women who experience multiple pregnancy have undergone prolonged and emotionally distressing treatment for infertility.
First trimester multifoetal pregnancy reduction (MFPR) can be performed in order to decrease the risk of complications associated with multiple gestations. The procedure of multifoetal reduction has in recent year become both clinically and ethically accepted as a therapeutic option in pregnancies with four or more fetuses [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] . In case of triplet gestation, this option remains controversial (4, 10, 11, (13) (14) (15) (16) (17) . With todays perinatal and neonatal care this outcome of triplets has improved considerably leading to low perinatal and neonatal mortality rate. Even then comparative studies showed better foetal outcome when triplets were reduced to twin in comparison to expectant management of triplets.
The procedure is invasive and not without risk. It may cause abortion and total foetal loss as well as maternal infections. So indications suggested by different researchers are i) Four or more embryos ii) Triplets having serious maternal diseases, poor uterine conditions, previous caeserean section, H/O previous preterm birth and embryo affected by serious diseases iii) Patient's request due to financial concern, mothers obligation to stop working, anticipating poor quality of life after birth of triplets and fear for distress during carrying triplets.
This descriptive study was carried out with an aim to evaluate maternal and foetal outcome after MFPR in multiple gestation more than two. Case selection and procedure : In eleven (11) cases, multifoetal pregnancy reduction were performed and maternal and foetal conditions were analyzed. All patients got pregnant after fertility treatment. Informed written consent was taken from all patients and their legal guardians. Patients were counseled regarding possibilities of abortion and maternal infection, bleeding and other rare complication like bleeding disorder. The procedure was done between 8-10 weeks of gestation except in one case which was done at 17 weeks, who had one anomalous foetus. Transvaginal approach through fornices under spinal anaesthesia was adopted for intracardiac injection of potassium chloride. Most accessible sac was targeted for reduction. In each foetus 1 ml potassium chloride was injected into heart and needle was kept there till cessation of cardiac pulsation. No complication occurred during the procedure. Prophylactic antibiotic cefixime 200 mg twice daily for 7 days, aspirin 75 mg daily till 34 weeks, antispasmodic tiemonium methyle sulphate 50 mg thrice daily for 7 days and progesterone Inj Gestone (Ferring) 50 mg daily for 20 weeks of gestation were used for all patients. Patients were monitored by USG weekly for first two weeks, monthly till 20 weeks and according to need afterwards. Coagulation profile was checked after two weeks of the procedure and in each month till 20 weeks of gestation. Main outcome measures were uterine contraction, leaking membrane, bleeding, infection, abortion, gestational age and birth weight.
Materials and methods:

Results:
Number of fetuses and their indications for reduction are given on table-I. Out of these eleven patients, eight patients had multiple gestations due to ART procedures while the remaining three patients had been treated with ovulation inducing drugs. Eight patients delivered twins at 37 weeks and their antenatal period was uneventful except one patient who suffered from leaking membrane and infection (table-II). One patient delivered twins at 34 weeks due to premature ruptured membrane. Unfortunately two patients had abortions, one was missed abortion. There was no perinatal death among 18 babies. Each of the babies born had an average weight of 2.42 kg. There was no serious maternal complication except rise of temperature in one patient. 
Discussion:
Multiple gestation present a significant increase in fetal growth abnormalities in direct relationship to the number of fetuses present. Healthy embryos are sacrificed in order to maximize the chances of survival of the remaining embryos or to allow the mother to choose the number of babies she wishes to deliver. Multifoetal pregnancy reduction reduces extreme prematurity before 32 weeks and improves foetal growth without excessive foetal loss. The ultrasonic prospective observation of expectantly managed triplet pregnancies reveals that fetal death is common before 24 weeks. Lipitz et al 18 reported a spontaneous fetal loss rate among expectantly managed triplets of nearly 21% before 24 weeks. Kol et al. 19 reports that spontaneous fetal death occurred in 5% of multiple pregnancies. These data suggest that the spontaneous loss rate in women carrying three fetuses may be similar to, or even higher than, the fetal loss rate observed following MFPR. Late MFPR at the midterm (20 weeks) could lead to a more favorable perinatal outcome. Delaying the procedure as late as 20 weeks may facilitate the detection of structural and chromosomal anomalies of the fetuses. However, studies are requested on larger series that should include only triplets with normal embryos in an effort to achieve homogeneity. Reducing qudruplets to twin has tremendous beneficial effect. There is debate about reducing triplets to twin but many researchers showed significant decrease in prematurity in reduced group. Lipitz et al showed 67.9% preterm births (36 weeks) among expectant group vs 16.1 % among reduced group 20 . Macones et al showed 43% birth before 32 weeks in non reduced triplets vs 4% in reduced twins 21 . Other researchers [22] [23] [24] suggested that a reduction from triplet to twin decreases the risk of extreme prematurity, and consequently that it may reduce the risk of cerebral palsy linked to intraventricular haemorrhage. Neonatal intensive care, ventilatory support and perinatal mortality was higher in non reduced triplets than reduced twins 21, 22 . Bollen et al 25 reported that 8% of surviving triplets suffer from neurological sequelae and this percentage may be higher because many of these infants were too young to permit full evaluation. Although MFPR decreases the number of babies going home per couple, it may increase the proportion of surviving infants without complications.
It should be noted, that MFPR on triplets is performed in several centres: in one study 42% of the 1084 procedures performed were for reducing triplets 26 . This rate is similar for a later expanded series including 1789 gestations out of which 759 were triplets 27 . In a French national study, 41% of 262 cases of reductions performed were on triplets 28 . Similar data are reported from monocentric series, with a mean rate of 24% -57.5% 29-34. MFPR in triplets (resulting in twins and less often in singletons) should be considered in pregnancies with serious maternal disease (e.g. heart disease, diabetes), poor uterine conditions (bicornuate uterus, exposure to diethylstilboestrol, previous caesarean section, previous preterm delivery) or in cases where an embryo is affected by a severe disease (neural tube defect, cystic hygroma). In the absence of worrisome factors, one might consider that the decision belongs to the well-informed couple. The results shown above indicate that reduction of triplets improves some obstetric parameters. In addition psychological health and the relationship with the children were more satisfactory in the reduction grouping in comparison to non reduced group. Families with triplets had much more acute psychosocial problems than families who underwent MFPR.
In our series majority MFPR was done to reduce triplets. The indication of reduction is shown in There was no serious maternal complication except rise of temperature in one patient, who had one anomalous baby. Five days after the procedure patient developed leaking membrane of existing sac and subsequently rise of temperature and uterine contraction. After addition of antibiotics temperature subsided but remaining two foetuses were expelled out. Though the number is very low in present study it gave us an impression of safety and rationality of the procedure.
Conclusion
The desire for a child is best fulfilled by a singletone or twin pregnancy rather than triplets or more. It seems that fetoreduction can improve the chances of survival and can reduce perinatal morbidity of remaining foetuses. Though number of cases are too small to draw any conclusion, we did not find any adverse affect after fetoreduction. It can reduce premature delivery and cost of intensive care and can reduce maternal distress of carrying three or more fetuses. So MFPR applied on higher order multiple pregnancies is a reasonable option of management and should be accepted if requested.
